← Eichor
Study identifier: NCT05841732 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

MyBack - A Behavior Change Informed Exercise Program to Prevent Low Back Pain Recurrences

Condition: Low Back Pain  ·  Sponsor: Instituto Politécnico de Setúbal

PhaseNA
Planned participants186
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersYes

About this study

Low Back Pain is a common heath condition with high rates of recurrence and huge associated costs. Research has focused its efforts on analysing the effects of interventions while knowledge about effective secondary prevention strategies is limited. MyBack study aims to analyse the effectiveness of a tailored exercise and behavioural change program (MyBack program) in the secondary prevention of low back pain, and evaluate acceptability, feasibility and determinants of implementation by the different stakeholders, as well as the implementation strategy of the MyBack program, through a hybrid type I, randomized, controlled and multicentre study of effectiveness and implementation in the context of primary health care.

This description comes directly from the study's public registry record.

Talk to the study team

Eduardo Cruz, PhD  ·  +365 265 709 300  ·  eduardo.cruz@ess.ips.pt

Always discuss trial participation with your own doctor first.

Locations (1)

Instituto Politécnico de SetúbalSetúbal, Setúbal District, PortugalRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05841732